GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity.
about
Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells.The Heat-Stable Enterotoxin Receptor, Guanylyl Cyclase C, as a Pharmacological Target in Colorectal Cancer Immunotherapy: A Bench-to-Bedside Current Report.Chimeric Antigen Receptor-Modified T Cells Redirected to EphA2 for the Immunotherapy of Non-Small Cell Lung Cancer.Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer MetastasesThe swinging pendulum of cancer immunotherapy personalization
P2860
GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity.
@en
type
label
GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity.
@en
prefLabel
GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity.
@en
P2093
P2860
P50
P1433
P1476
GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity.
@en
P2093
Crystal L Kraft
Glen P Marszalowicz
Tara S Abraham
Trevor R Baybutt
P2860
P304
P356
10.1080/2162402X.2016.1227897
P577
2016-09-02T00:00:00Z